| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 153.628 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 165.437 | 82 |
| GSM780709 | Untreated after 4 days (C3_1) | 169.628 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 162.578 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 149.779 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 152.494 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 143.816 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 153.553 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 157.979 | 81 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 156.192 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 142.577 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 146.516 | 80 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 146.219 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 135.861 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 120.288 | 78 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 151.386 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 136.753 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 146.952 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 143.874 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 146.343 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 137.552 | 79 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 160.217 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 157.053 | 81 |